Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Organon Obtains Rights To Perjeta, Prolia/Xgeva Biosimilars From Shanghai Henlius

Jun 15 2022

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

Organon Strikes $100m+ Global Deal For Henlius’ Denosumab And Pertuzumab

Jun 13 2022

Alvotech On The Verge Of New Chapter As SPAC Merger Is Approved

Jun 09 2022

OWKIN CEO Outlines AI's 'Transfer Learning' Promise In Drug Discovery

Jan 19 2018

Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology

Nov 18 2021

Deal Watch: BMS Licenses Bispecific TCR Candidate From Immatics

Dec 17 2021

Organon Is Serious About Building A Women's Health Company, Deal By Deal

Jun 03 2021

Vertex Spots Potential Bargain Of $60m Entry Into Complement Regulation

May 24 2022

GSK Spies Pfizer Challenge With $2.1bn Vaccine Company Acquisition

May 31 2022

EW Healthcare Partners Adds Women’s Health Heft With TherapeuticsMD Buyout

May 31 2022

As Its Debut Cancer Drug Struggles, MorphoSys Continues Refocus With $1bn Licensing Deal

Jun 15 2022

Boehringer To Acquire Trutino Under Aggressive Cancer R&D Strategy

Jun 15 2022

CureVac Frames Comeback With Dutch Biotech Buy

Jun 10 2022

BMS Hopes Turning Point Buyout Will Fare Better Than Roche’s Ignyta Acquisition

Jun 03 2022

Yumanity To Reverse Merge With Kineta Two Years After Its Own Public Debut

Jun 06 2022

Regeneron Takes Full Libtayo Rights As March Into Oncology Progresses

Jun 02 2022

Repare Gets Cash And Validation In DNA Damage Repair Alliance With Roche

Jun 02 2022

Upstream Launches With $200m To Buy, Develop Drugs For Immune-Mediated Diseases

Jun 02 2022

Despite BMS Bid, Celgene Pays $75m Upfront For Immatics Assets Options

Aug 28 2019

Related Companies

Shanghai Henlius Biotech Co. Ltd.

Genentech, Inc.

Amgen, Inc.

Merck & Co., Inc.

Oxford BioTherapeutics

ImmunoGen, Inc.

Alectos Therapeutics Inc.

Biogen, Inc.

Celgene Corporation

Immatics N.V.

Endo, Inc.

Umoja Biopharma, Inc.

Lupagen, Inc.

Evotec SE

Janssen Pharmaceutica NV

Nevakar, Inc.

Laboratoires Thea

Olema Pharmaceuticals, Inc.

Aurigene Oncology

Dr. Reddy's Laboratories Ltd.

UCB S.A.

Roswell Biotechnologies

OnCusp Therapeutics

Multitude Therapeutics

Medison Pharma Ltd.

argenx N.V.

Proxygen

4P Pharma

SunRock Biopharma

Ellipses Pharma Ltd.

RS BioTherapeutics, Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window